NCT04476407View on ClinicalTrials.gov

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

June 15, 2019

Primary Completion Date

October 21, 2019

Study Completion Date

October 21, 2019

Conditions
Complicated Urinary Tract Infection; Cuti
Interventions
DRUG

benapenem

single-dose Benapenem 1.0mg(iv), 60min infusion

DRUG

benapenem

single-dose Benapenem 1.0mg(iv), 60min infusion

DRUG

benapenem

single-dose Benapenem 1.0mg(iv), 60min infusion

Trial Locations (1)

200092

Shanghai Tongji Hospital, Shanghai

All Listed Sponsors
lead

Sihuan Pharmaceutical Holdings Group Ltd.

INDUSTRY

NCT04476407 - Pharmacokinetics of Benapenem in Subjects With Renal Impairment | Biotech Hunter | Biotech Hunter